The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wu Mijia since 2019.
This trader's CIK number is 1664299.
At the time of last reporting, Wu Mijia was the Director of Novabay Pharmaceuticals, Inc.. (stock ticker symbol NBY).
Also see all insider trading activities at Novabay Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | NBY | 0 | $0 | 0 | $0 | 858 | $0 |
| 2022 | NBY | 0 | $0 | 0 | $0 | 30,000 | $0 |
| 2020 | NBY | 0 | $0 | 20,000 | $27,000 | 0 | $0 |
| 2019 | NBY | 0 | $0 | 63,492 | $160,792 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-11 | NBY | Option Ex | 858 | .00 | 0 |
| 2022-05-21 | NBY | Option Ex | 30,000 | .00 | 0 |
| 2020-08-17 | NBY | Sale | 20,000 | 1.35 | 27,000 |
| 2019-06-11 | NBY | Sale | 15,873 | 4.04 | 64,126 |
| 2019-06-10 | NBY | Sale | 47,619 | 2.03 | 96,666 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wu Mijia (Director of Novabay Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.